Recall Z-1518-2025— BioFire Diagnostics, LLC

Class II · Ongoing

Class II FDA medical device recall by BioFire Diagnostics, LLC, initiated 2025-02-27. It names 3 FDA 510(k) clearances: K243222, K222601, K181324. Product: FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374. Reason: Increased risk of control failures and false negative test results with multiplexed nucleic acid test..

Recalling firm
BioFire Diagnostics, LLC
Classification
Class II
Status
Ongoing
Initiated
2025-02-27
Firm location
Salt Lake City, UT, United States

510(k) clearances named in this recall

3 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374

Reason for recall

Increased risk of control failures and false negative test results with multiplexed nucleic acid test.

Data sourced from openFDA. This site is unofficial and independent of the FDA.